Skip Navigation



Annals of Oncology Advance Access published online on April 13, 2007
Annals of Oncology, doi:10.1093/annonc/mdm108
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/11/1774    most recent
mdm108v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herbertson, R.
Right arrow Articles by Scott, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbertson, R.
Right arrow Articles by Scott, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

review

The expanding role of PET technology in the management of patients with colorectal cancer

RA Herbertson1,2,*, ST Lee1,3,4, N Tebbutt1,2 and AM Scott1,3,4

1 Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences
2 Ludwig Institute Oncology Unit
3 Centre for Positron Emission Tomography
4 Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

* Correspondence to: Dr R. A. Herbertson, Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, 1st Floor, Harold Stokes Building, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084 Australia. Tel: +61-394963098; Fax: +61-94965892; E-mail: rebecca.herbertson{at}ludwig.edu.au

The therapeutic options and subsequent survival of colorectal cancer (CRC) patients has increased substantially over recent years. While surgical excision of the primary cancer results in cure of ~50% of patients, recurrence and metastatic disease still remains a significant cause of death. Although resection of liver or lung metastases can result in cure, relapse rates remain high, indicating that patient selection needs improvement. Positron emission tomography (PET) technology has a great deal to offer with respect to CRC management, particularly in the setting of patient selection for metastasectomy and in the evaluation of possible recurrent disease, however it has not yet become a routine part of the management of all CRC patients. This review article aims to discuss the current and future implications of PET technology in the optimal management of CRC patients throughout their care pathway.

colorectal cancer, positron emission tomography

Received for publication January 21, 2007. Revision received February 20, 2007. Accepted for publication February 20, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. Bystrom, A. Berglund, U. Garske, H. Jacobsson, A. Sundin, P. Nygren, J.-E. Frodin, and B. Glimelius
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
Ann. Onc., June 1, 2009; 20(6): 1057 - 1061.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.